Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Stake in Xometry, Inc. (NASDAQ:XMTR)

Xometry logo with Industrials background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased its holdings in shares of Xometry, Inc. (NASDAQ:XMTR - Free Report) by 88.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 67,238 shares of the company's stock after selling 495,709 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.14% of Xometry worth $2,868,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in XMTR. Global Retirement Partners LLC purchased a new stake in shares of Xometry in the 4th quarter valued at about $27,000. Canada Pension Plan Investment Board acquired a new position in Xometry during the fourth quarter worth approximately $38,000. Comerica Bank lifted its stake in Xometry by 195.1% in the fourth quarter. Comerica Bank now owns 1,133 shares of the company's stock valued at $48,000 after buying an additional 749 shares during the last quarter. CoreCap Advisors LLC purchased a new stake in Xometry in the fourth quarter valued at approximately $51,000. Finally, SBI Securities Co. Ltd. acquired a new stake in shares of Xometry in the fourth quarter valued at approximately $73,000. Hedge funds and other institutional investors own 97.31% of the company's stock.

Insider Buying and Selling at Xometry

In other Xometry news, CFO James Miln sold 1,346 shares of the firm's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $25.13, for a total value of $33,824.98. Following the completion of the sale, the chief financial officer now owns 144,713 shares of the company's stock, valued at approximately $3,636,637.69. This trade represents a 0.92% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Emily Rollins sold 2,000 shares of the stock in a transaction dated Monday, April 7th. The shares were sold at an average price of $20.66, for a total transaction of $41,320.00. Following the completion of the transaction, the director now owns 16,146 shares of the company's stock, valued at $333,576.36. This represents a 11.02% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 24,644 shares of company stock valued at $666,660. 9.66% of the stock is owned by corporate insiders.

Xometry Stock Performance

Shares of XMTR stock traded down $0.55 during mid-day trading on Monday, hitting $36.20. The stock had a trading volume of 271,164 shares, compared to its average volume of 601,769. The firm has a market cap of $1.83 billion, a PE ratio of -34.48 and a beta of 0.84. The company's 50-day simple moving average is $27.94 and its 200-day simple moving average is $31.24. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.59 and a quick ratio of 4.55. Xometry, Inc. has a fifty-two week low of $11.08 and a fifty-two week high of $45.33.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on the stock. JPMorgan Chase & Co. lifted their target price on shares of Xometry from $36.00 to $38.00 and gave the company an "overweight" rating in a report on Tuesday, June 3rd. Royal Bank of Canada lifted their price objective on shares of Xometry from $32.00 to $36.00 and gave the company a "sector perform" rating in a research note on Wednesday, May 7th. JMP Securities reaffirmed a "market outperform" rating and issued a $42.00 target price on shares of Xometry in a report on Monday, February 10th. UBS Group increased their target price on shares of Xometry from $33.00 to $35.00 and gave the stock a "neutral" rating in a research note on Wednesday, May 7th. Finally, The Goldman Sachs Group raised their price target on Xometry from $30.00 to $33.00 and gave the stock a "buy" rating in a report on Thursday, May 8th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $35.78.

Read Our Latest Stock Analysis on XMTR

About Xometry

(Free Report)

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Read More

Institutional Ownership by Quarter for Xometry (NASDAQ:XMTR)

Should You Invest $1,000 in Xometry Right Now?

Before you consider Xometry, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.

While Xometry currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA: Another 200% Growth Ahead? (PLUS 2 Companies Riding Along)
3 Rising Stocks You’ll Want on Your Watchlist
Trillions in Defense Spending—3 Disruptive Stocks Set to Double

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines